Triacin-c

   
Google
 
Web NewDrugInformation.com

Triacin-c


Drug - Triacin-c
The trade name of the product as shown on the labeling.

Dosage - SYRUP; ORAL
The product dosage form and route separated by a semi-colon.

Active Ingredient(s) - Codeine Phosphate; Pseudoephedrine Hydrochloride; Triprolidine Hydrochloride
Multiple ingredients are in alphabetical order.

Strength - 10MG/5ML;30MG/5ML;1.25MG/5ML
The potency of the active ingredient(s), Codeine Phosphate; Pseudoephedrine Hydrochloride; Triprolidine Hydrochloride. May repeat for multiple part products.

Applicant - ALPHARMA US PHARMS
The firm name holding legal responsibility for Triacin-c. The firm name is condensed to a maximum twenty character unique string.

New Drug Application (NDA) Number - 088704
The FDA assigned number to Triacin-c. Format is nnnnnn.

Product Number - 001
The FDA assigned number to identify Triacin-c. Each strength is a separate product. May repeat for multiple part products. Format is nnn.

Therapeutic Equivalence (TE) Code - AA
The TE Code indicates the therapeutic equivalence rating of generic to innovator Rx products.

Approval Date - Mar 22, 1985
The date Triacin-c was approved as stated in the FDA approval letter to the applicant. The format is Mmm dd, yyyy. Products approved prior to the January 1, 1982 contain the phrase: "Approved prior to Jan 1, 1982".

Reference Listed Drug (RLD) - No
The pioneer or innovator of Triacin-c. The RLD identifies the product Abbreviated New Drug Applications (ANDA) use as a reference. Format is Yes or No.

Type - RX
The group or category of approved drugs Triacin-c is in. Format is RX, OTC, DISCN.

Applicant Full Name - Alpharma Us Pharmaceuticals Division
The full name of the firm holding legal responsibility for the new application of Triacin-c.

Triacin-c